Detalhe da pesquisa
1.
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.
Nature
; 596(7871): 268-272, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107529
2.
Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine.
Immunol Rev
; 310(1): 47-60, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689434
3.
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med
; 386(9): 847-860, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139271
4.
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med
; 384(23): 2187-2201, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882225
5.
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
N Engl J Med
; 384(19): 1824-1835, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440088
6.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
J Infect Dis
; 227(6): 761-772, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904987
7.
Impact of Preexisting Anti-Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine.
J Infect Dis
; 226(6): 979-982, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429381
8.
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.
J Infect Dis
; 223(9): 1576-1581, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887990
9.
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
JAMA
; 325(15): 1535-1544, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704352
10.
Respiratory syncytial virus acute respiratory infections in ≥ 65-year-old adults in long-term care facilities in the Czech Republic.
Cent Eur J Public Health
; 29(3): 167-176, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623114
11.
Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial.
Int J Cancer
; 147(1): 170-174, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736068
12.
Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine.
Pharmacoepidemiol Drug Saf
; 29(9): 1159-1167, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583515
13.
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
J Infect Dis
; 219(11): 1799-1803, 2019 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715452
14.
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
N Engl J Med
; 385(6): 571, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289270
15.
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
N Engl J Med
; 385(10): 951-953, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260834
16.
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
J Infect Dis
; 215(11): 1711-1719, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591778
17.
Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9-14 Years Versus a 3-Dose Regimen in Women Aged 15-25 Years.
J Infect Dis
; 214(4): 525-36, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908726
18.
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
Int J Cancer
; 138(10): 2428-38, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26685704
19.
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
Int J Cancer
; 139(12): 2812-2826, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27541373
20.
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Lancet Oncol
; 16(7): 775-86, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26071347